Taxane-based chemohormonal therapy for metastatic hormone-sensitive prostate cancer
Sathianathen NJ., Philippou YA., Kuntz GM., Konety BR., Lamb AD., Dahm P.
© 2017 The Cochrane Collaboration. Published by John Wiley & Sons, Ltd. This is a protocol for a Cochrane Review (Intervention). The objectives are as follows: To assess the effects of immediate taxane-based chemohormonal therapy for newly diagnosed metastatic hormone-sensitive prostate cancer.